Details for New Drug Application (NDA): 217467
✉ Email this page to a colleague
The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 217467
| Tradename: | OSELTAMIVIR PHOSPHATE |
| Applicant: | Invagen Pharms |
| Ingredient: | oseltamivir phosphate |
| Patents: | 0 |
Pharmacology for NDA: 217467
| Mechanism of Action | Neuraminidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 217467
Suppliers and Packaging for NDA: 217467
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 217467 | ANDA | Exelan Pharmaceuticals, Inc. | 76282-702 | 76282-702-45 | 10 CAPSULE in 1 BLISTER PACK (76282-702-45) |
| OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 217467 | ANDA | Exelan Pharmaceuticals, Inc. | 76282-703 | 76282-703-45 | 10 CAPSULE in 1 BLISTER PACK (76282-703-45) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
| Approval Date: | Oct 3, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
| Approval Date: | Oct 3, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Oct 3, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
